Your browser doesn't support javascript.
loading
SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro.
Zilio, Gianluca; Masato, Anna; Sandre, Michele; Caregnato, Alberto; Moret, Francesca; Maciola, Agnieszka Katarzyna; Antonini, Angelo; Brucale, Marco; Cendron, Laura; Plotegher, Nicoletta; Bubacco, Luigi.
Afiliação
  • Zilio G; Department of Biology, University of Padova, Padova 35131, Italy.
  • Masato A; Department of Biology, University of Padova, Padova 35131, Italy.
  • Sandre M; Department of Biology, University of Padova, Padova 35131, Italy.
  • Caregnato A; Department of Neuroscience, University of Padova, Padova 35121, Italy.
  • Moret F; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova 35131, Italy.
  • Maciola AK; Department of Biology, University of Padova, Padova 35131, Italy.
  • Antonini A; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova 35128, Italy.
  • Brucale M; Department of Neuroscience, University of Padova, Padova 35121, Italy.
  • Cendron L; Consiglio Nazionale delle Ricerche, Istituto per lo Studio dei Materiali Nanostrutturati, Bologna 40129, Italy.
  • Plotegher N; Department of Biology, University of Padova, Padova 35131, Italy.
  • Bubacco L; Department of Biology, University of Padova, Padova 35131, Italy.
ACS Chem Neurosci ; 15(2): 215-221, 2024 01 17.
Article em En | MEDLINE | ID: mdl-38131609
ABSTRACT
Since the SARS-CoV-2 virus started spreading worldwide, evidence pointed toward an impact of the infection on the nervous system. COVID-19 patients present neurological manifestations and have an increased risk of developing brain-related symptoms in the long term. In fact, evidence in support of the neuroinvasive potential of SARS-CoV-2 has emerged. Considering that viral parkisonism was observed as a consequence of encephalopathies caused by viral infections, it has been already suggested that COVID-19 could affect the dopaminergic neurons and contribute to neurodegeneration in Parkinson's disease (PD), by promoting the formation of amyloid fibrils constituted by the PD-related protein α-synuclein. Here, we observe not only that SARS-CoV-2 viral spike protein and nucleocapsid protein can alone promote α-synuclein aggregation but also that the spike protein organization in a corona shape on the viral envelope may be crucial in triggering fast amyloid fibrils formation, thus possibly contributing to PD pathogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / COVID-19 Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / COVID-19 Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália